Michael James Newman Indaptus Therapeutics, Inc. (INDP) insider trading activity
Michael James Newman is CSO and Director of Indaptus Therapeutics, Inc.. Currently has a direct ownership of 101,074 shares of INDP, which is worth approximately $253,695. The most recent transaction as insider was on Dec 22, 2025, when has been sold 52,204 shares (Common Stock) at a price of $2.03 per share, resulting in proceeds of $105,974. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
101K
n/a
3M change
n/a
12M change
Total Value Held
$253,695
MJN
Michael James Newman
CSO and Director
New York, NY